203 related articles for article (PubMed ID: 20593483)
1. Origin and evolution of somatic cell testicular tumours in transgenic mice.
Quintana S; Venara M; Rey R; di Clemente N; Chemes HE
J Pathol; 2010 Aug; 221(4):443-51. PubMed ID: 20593483
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
Rey R; Sabourin JC; Venara M; Long WQ; Jaubert F; Zeller WP; Duvillard P; Chemes H; Bidart JM
Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
[TBL] [Abstract][Full Text] [Related]
3. Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours.
Lobo MV; Arenas MI; Alonso FJ; Gomez G; Bazán E; Paíno CL; Fernández E; Fraile B; Paniagua R; Moyano A; Caso E
Cell Tissue Res; 2004 Jun; 316(3):369-76. PubMed ID: 15127288
[TBL] [Abstract][Full Text] [Related]
4. Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines.
Paquis-Flucklinger V; Michiels JF; Vidal F; Alquier C; Pointis G; Bourdon V; Cuzin F; Rassoulzadegan M
Oncogene; 1993 Aug; 8(8):2087-94. PubMed ID: 8393161
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of testicular cell lines from MT-PVLT-10 transgenic mice.
Lebel M; Mes-Masson AM
Exp Cell Res; 1994 Jul; 213(1):12-9. PubMed ID: 8020581
[TBL] [Abstract][Full Text] [Related]
6. Use of antibodies against LH receptor, 3beta-hydroxysteroid dehydrogenase and vimentin to characterize different types of testicular tumour in dogs.
Peters MA; Teerds KJ; van der Gaag I; de Rooij DG; van Sluijs FJ
Reproduction; 2001 Feb; 121(2):287-96. PubMed ID: 11226053
[TBL] [Abstract][Full Text] [Related]
7. Mitotic activity of Sertoli cells in adult human testis: an immunohistochemical study to characterize Sertoli cells in testicular cords from patients showing testicular dysgenesis syndrome.
Brehm R; Rey R; Kliesch S; Steger K; Marks A; Bergmann M
Anat Embryol (Berl); 2006 Jun; 211(3):223-36. PubMed ID: 16429274
[TBL] [Abstract][Full Text] [Related]
8. Non-tumoural parenchyma in Leydig cell tumours: pathogenetic considerations.
Cajaiba MM; Reyes-Múgica M; Rios JC; Nistal M
Int J Androl; 2008 Jun; 31(3):331-6. PubMed ID: 17573846
[TBL] [Abstract][Full Text] [Related]
9. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
Kurland G; Christensen AK; Huseby RA
Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
[TBL] [Abstract][Full Text] [Related]
10. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
[TBL] [Abstract][Full Text] [Related]
11. Canine testicular tumours: a study on 232 dogs.
Grieco V; Riccardi E; Greppi GF; Teruzzi F; Iermanò V; Finazzi M
J Comp Pathol; 2008; 138(2-3):86-9. PubMed ID: 18295787
[TBL] [Abstract][Full Text] [Related]
12. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
[TBL] [Abstract][Full Text] [Related]
13. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of calretinin in canine testicular tumours and normal canine testicular tissue.
Radi ZA; Miller DL
Res Vet Sci; 2005 Oct; 79(2):125-9. PubMed ID: 15924929
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of GATA-4 in canine testicular tumors.
Ramos-Vara JA; Miller MA
Vet Pathol; 2009 Sep; 46(5):893-6. PubMed ID: 19429994
[TBL] [Abstract][Full Text] [Related]
16. Switch of cadherin expression as a diagnostic tool for Leydig cell tumours.
Bremmer F; Schweyer S; Martin-Ortega M; Hammerlein B; Strauss A; Radzun HJ; Behnes CL
APMIS; 2013 Oct; 121(10):976-81. PubMed ID: 23398382
[TBL] [Abstract][Full Text] [Related]
17. Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats.
Dirami G; Teerds KJ; Cooke BA
Toxicol Appl Pharmacol; 1996 Nov; 141(1):169-77. PubMed ID: 8917689
[TBL] [Abstract][Full Text] [Related]
18. Leydig cell-specific expression of DAX1 improves fertility of the Dax1-deficient mouse.
Meeks JJ; Russell TA; Jeffs B; Huhtaniemi I; Weiss J; Jameson JL
Biol Reprod; 2003 Jul; 69(1):154-60. PubMed ID: 12606353
[TBL] [Abstract][Full Text] [Related]
19. Immunohistological determination of oestrogen receptor, progesterone receptor, and intermediate filaments in Leydig cell tumours, Leydig cell hyperplasia, and normal Leydig cells of the human testis.
Düe W; Dieckmann KP; Loy V; Stein H
J Pathol; 1989 Mar; 157(3):225-34. PubMed ID: 2466972
[TBL] [Abstract][Full Text] [Related]
20. The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice.
Kananen K; Markkula M; el-Hefnawy T; Zhang FP; Paukku T; Su JG; Hsueh AJ; Huhtaniemi I
Mol Cell Endocrinol; 1996 May; 119(2):135-46. PubMed ID: 8807633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
